Ignite Creation Date:
2024-05-06 @ 10:19 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03222583
Status:
COMPLETED
Last Update Posted:
2019-12-23
First Post:
2017-07-17
Brief Title:
A Study to Evaluate the Efficacy and Safety of GlecaprevirPibrentasvir ABT-493ABT-530 in Treatment-Naive and Treatment-Experienced Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype GT 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection
Sponsor:
AbbVie
Organization:
AbbVie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-04
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-17
First Submit QC Date:
July 17 2017
Study First Post Date:
2017-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-12-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-05
Last Update Post Date:
2019-12-23
Last Update Post Date Type:
ACTUAL